Benefits
Glycemia and Insulinemia Improvement
Nexira in vivo study (high fat/sucrose diet model) showed inavea™ CINNAMON ACACIA improves blood glucose and insulin markers vs HFHS-induced dysbiosis controls. Mechanism: cinnamon glucose modulation + acacia prebiotic effects.
Strong Prebiotic Activity
Significant ability to modulate overall gut microbiota population at 5 g/day; promotion of beneficial bacteria including Parabacteroides distasonis (whose benefits on metabolic health markers like glycemia and weight have been substantiated by Wang 2019 and others).
Increased SCFA Production (Propionate and Butyrate)
Specifically increases propionate and butyrate (SCFAs with metabolic health benefits) — propionate supports gluconeogenesis modulation and satiety; butyrate is colonocyte fuel and has insulin-sensitizing effects.
Microbiome Modulation Under Metabolic Stress
Studied specifically under dysbiosis-inducing conditions (high fat / high sucrose diet) — demonstrates effects in challenging metabolic environments. Relevant to: Western diet patterns, prediabetes, metabolic syndrome contexts.
Dual Mechanism (Polyphenols + Fiber)
Combines cinnamon polyphenols (direct insulin-mimetic and antioxidant effects) with acacia prebiotic fiber (indirect microbiome-mediated metabolic effects). Distinct mechanisms with complementary metabolic benefits.
Subtle Cinnamon Taste
Pleasant warming cinnamon flavor; suitable for: warm beverages, baked goods, breakfast applications, functional shots.
Mechanism of action
Cinnamon Polyphenol Metabolic Effects
Cinnamon contains POLYPHENOLS including PROANTHOCYANIDINS (PACs), CINNAMTANNINS (B-type PACs unique to cinnamon), and other polyphenols. Mechanisms: insulin-mimetic effects (insulin receptor stimulation), enhanced glucose uptake in muscle/adipose, modulation of carbohydrate digestion enzymes.
Acacia Prebiotic Mechanism
Acacia gum supports beneficial bacteria, SCFA production, gut barrier — see acacia/Fibregum entries. Foundation for indirect metabolic benefits.
Parabacteroides distasonis Promotion
Specific bacterial species shown to support metabolic health markers (glycemia, weight); inavea™ CINNAMON ACACIA selectively promotes this beneficial species.
Propionate/Butyrate Specificity
Among SCFAs, propionate and butyrate are particularly metabolically active — increased production from this formulation supports specific metabolic health pathways.
Clinical trials
In vivo study of inavea™ CINNAMON ACACIA in high fat/high sucrose diet-induced dysbiosis model.
In vivo model under metabolic stress conditions.
Strong prebiotic activity, synergistic gut microbiome balance contribution, significant role in metabolic health improvement (glycemia and insulinemia).
Trial of cinnamon on glycemic markers in T2D patients.
T2D patients.
Cinnamon reduced fasting glucose and HbA1c. Established cinnamon-specific glycemic effects (foundation for combination formulations).
About this ingredient
INAVEA™ CINNAMON ACACIA is an ORGANIC SYNERGISTIC FORMULATION developed by NEXIRA (France) — combining CINNAMON (Cinnamomum verum / Cinnamomum cassia) and ACACIA gum (Acacia senegal/seyal). Both ingredients have long history within Nexira portfolio. POSITIONING: 'METABOLIC HEALTH ACTIVATOR' — combines two mechanisms: cinnamon polyphenols for insulin/glucose effects, acacia gum for prebiotic effects. CINNAMON BOTANY: inner bark of tropical evergreen tree; CEYLON CINNAMON (Cinnamomum verum) is 'true cinnamon' with low coumarin; CASSIA CINNAMON (Cinnamomum cassia) is more common commercial type with higher coumarin content; Nexira specifies LOW COUMARIN content — important for chronic supplementation safety.
EVIDENCE-BASED USES: (1) METABOLIC HEALTH (glycemia, insulinemia improvement); (2) Strong prebiotic activity; (3) Microbiome balance under metabolic stress; (4) SCFA production (propionate, butyrate); (5) Parabacteroides distasonis promotion (metabolically beneficial bacteria); (6) Functional beverage/food fortification.
KEY DISTINCTIONS: (1) GLYCEMIC + PREBIOTIC dual mechanism; (2) STUDIED UNDER DYSBIOSIS CONDITIONS (HFHS diet model); (3) SPECIFIC METABOLIC SCFAs (propionate, butyrate); (4) LOW COUMARIN cinnamon source; (5) CARBON NEUTRAL ORGANIC.
CRITICAL CAUTIONS: (1) COUMARIN CONTENT — cassia cinnamon contains coumarin (potential hepatotoxin and anticoagulant at high doses); EFSA TDI 0.1 mg/kg body weight; Nexira specifies low coumarin content for safe long-term use; verify product specifications; (2) DIABETES MEDICATIONS — additive hypoglycemic effects; monitor glucose; (3) PREGNANCY — moderate cinnamon culinary use safe; concentrated supplementation limited safety data; AVOID high-dose supplementation; (4) LACTATION — moderate use safe; high-dose supplementation limited data; (5) ANTICOAGULANTS — coumarin theoretical interaction with warfarin; modest at properly-formulated low-coumarin products; (6) HEPATIC IMPAIRMENT — coumarin metabolism via liver; AVOID with significant liver disease; (7) DOSE — 5 g/day research-validated; 'high fiber content' claims achievable; (8) APPLICATIONS — capsules, sticks, shots for supplements; warm beverages (cinnamon-infused), baked goods, breakfast products; (9) inavea™ FAMILY DIFFERENTIATION — CINNAMON ACACIA (metabolic health, warming spice); BAOBAB ACACIA (digestive, fruity); CAROB ACACIA (diversity, cocoa-like); PURE ACACIA (neutral); choose by application; (10) FOR METABOLIC SYNDROME / PREDIABETES — comprehensive lifestyle approach (diet, exercise, weight management) is foundational; inavea™ CINNAMON ACACIA may complement; (11) PARABACTEROIDES DISTASONIS — emerging research on this beneficial gut bacteria's metabolic effects; Wang 2019 documented benefits; selective promotion is novel positioning; (12) BRAND VERIFICATION — inavea™ CINNAMON ACACIA is Nexira trademark; specific clinical evidence and low-coumarin specification on this proprietary formulation; (13) For BLOOD SUGAR SUPPORT — combines two evidence-based mechanisms (cinnamon, prebiotic fiber) in single ingredient; reasonable component of metabolic health protocols.